Brief: Timber Pharmaceuticals To Be Acquired By Leo Pharma
Aug 21 (Reuters) -
* TIMBER PHARMACEUTICALS TO BE ACQUIRED BY LEO PHARMA
* TIMBER PHARMACEUTICALS INC - TOTAL TRANSACTION VALUE OF UP
TO
$36 MILLION
* TIMBER PHARMACEUTICALS- TRANSACTION HAS BEEN UNANIMOUSLY
APPROVED BY BOARDS OF DIRECTORS OF BOTH COMPANIES AND IS
EXPECTED TO CLOSE IN Q4 OF 2023
* TIMBER PHARMACEUTICALS INC - FOLLOWING COMPLETION OF
TRANSACTION, TIMBER WILL BECOME A PRIVATELY HELD COMPANY
Source text for Eikon: ID:nGNX5kTY7K
Further company coverage: TMBR.A
((reuters.briefs@thomsonreuters.com))
Recent news on Trex Wind-Down
See all newsBrief: NYSE American To Suspend Trading Immediately In Timber Pharma
Brief: Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business
Brief: NYSE American to Commence Delisting Proceedings Against Timber Pharmaceuticals
Brief: Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A "Stalking Horse" Asset Purchase Agreement
Brief: Timber Pharmaceuticals Inc Files For Voluntary Chapter 11 Bankruptcy - Court Filing